Pharmacological inhibition with the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; generally known as FRAP-associated protein (FRP1)) has emerged as a promising system for cancer therapy that exploits synthetic lethal interactions with proteins involved with DNA damage maintenance, overcomes resistance to other therapies and enhances antitumour immunity. A... https://simondozmw.loginblogin.com/33008438/trovafloxacin-mesylate-things-to-know-before-you-buy